Pegbelfermin (BMS-986036), a PEGylated fibroblast growth...

  • Main
  • 2018 / 12
  • Pegbelfermin (BMS-986036), a PEGylated fibroblast growth...

Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial

Sanyal, Arun, Charles, Edgar D, Neuschwander-Tetri, Brent A, Loomba, Rohit, Harrison, Stephen A, Abdelmalek, Manal F, Lawitz, Eric J, Halegoua-DeMarzio, Dina, Kundu, Sudeep, Noviello, Stephanie, Luo,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(18)31785-9
Date:
December, 2018
File:
PDF, 452 KB
english, 2018
Conversion to is in progress
Conversion to is failed